Can-Fite Expands Namodenoson anti-Obesity Franchise with Israeli Patent Allowance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/19/2026

1. NVDA
2. METC
3. SPY
4. DOO
5. HD
6. AMLX
7. ARGX
8. INFQ

Go back to Can-Fite Expands Namodenoson anti-Obesity Franchise with Israeli Patent Allowance
CAN-FITE BIOPHARMA LTD. (NYSE: CANF) Delayed: 3.45 -0.13 (3.63%)
Previous Close $3.58    52 Week High $3.89 
Open $3.54    52 Week Low $1.85 
Day High $3.56    P/E N/A 
Day Low $3.37    EPS $0.00 
Volume 34,061       

CAN-FITE BIOPHARMA LTD. (NYSE: CANF) Delayed: 3.45 -0.13 (3.63%)
Previous Close $3.58    52 Week High $3.89 
Open $3.54    52 Week Low $1.85 
Day High $3.56    P/E N/A 
Day Low $3.37    EPS $0.00 
Volume 34,061       

(NASDAQ: CFBI) Delayed: 10.08 --0 (-0%)
Previous Close $10.08    52 Week High $ 
Open $41.64    52 Week Low $ 
Day High $10.08    P/E N/A 
Day Low $10.08    EPS $ 
Volume 206